EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparison of agranulocytosis and anti‐neutrophil cytoplasmic antibody‐associated vasculitis caused by two antithyroid drugs: A pharmacovigilance study using the WHO international database

Ji Yun Han, Jun Myong Lee iD, Se Yong Jung, Min Seo Kim, Seung Won Lee, Andreas Kronbichler, Kalthoum Tizaoui, Ai Koyanagi, Eun Young Kim iD, Kyungchul Song, Hyun Wook Chae, Dong Keon Yon und 2 weitere

Fundamental & Clinical Pharmacology · 2024-08 · 38 (4) · 780-788

DOI: 10.1111/fcp.12991 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Fundamental & Clinical Pharmacology, online erschienen am 11.02.2024. Verfasst von Ji Yun Han und 13 weiteren Autor:innen. Beteiligte Einrichtung: Seoul National University Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Antithyroid Agents, Agranulocytosis, Pharmacovigilance, Propylthiouracil. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Methimazole (MMI) and propylthiouracil (PTU) are commonly used for patients with thyrotoxicosis. Agranulocytosis and antineutrophil cytoplasmic antibody (ANCA)‐associated vasculitis (AAV) is associated with high morbidity and mortality, requiring appropriate interventions. In this study, we compared adverse drug effects associated with MMI and PTU using a real‐world large pharmacovigilance database.

Methods

We searched all Individual Case Safety Reports reported to be associated with MMI and PTU, from VigiBase between 1967 and June 2, 2021. We conducted disproportionality analysis (case/non‐case analysis) to analyze the difference in reported adverse drug reactions (ADRs) between antithyroid drugs (case) and the entire database (non‐cases). We further analyzed information for the cases of agranulocytosis and AAV.

Results

Among 11 632 cases of ADRs reported after MMI intake, agranulocytosis occurred in 1633 cases and AAV occurred in 41 cases. For 5055 cases of ADRs reported after PTU intake, agranulocytosis occurred in 459 cases and AAV occurred in 110 cases. Agranulocytosis occurred after a median of 28 days after PTU intake and 33 days after MMI intake. More than 95% of the agranulocytosis cases were classified as serious, but most of them (65.1% for PTU and 70.4% for MMI) were reported to have recovered after dechallenge actions; mostly drug withdrawal. AAV occurred after a median of 668 days after PTU intake, and 1162 days after MMI intake.

Conclusions

This is a pharmacoepidemiological study investigating agranulocytosis and AAV caused by MMI and PTU. Through this research, we could provide more specific insights into a safe prescription of antithyroid drugs in a real‐world setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antithyroid AgentsAgranulocytosisPharmacovigilancePropylthiouracilMethimazoleAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisDatabases, FactualHumansFemaleMaleMiddle AgedAdultAdverse Drug Reaction Reporting SystemsAgedWorld Health OrganizationYoung AdultAdolescent

Stichwörter der Autor:innen

ANCA‐associated vasculitisAntithyroid drugsagranulocytosismethimazolepharmacovigilance studypropylthiouracil

Substanzen

Antithyroid AgentsPropylthiouracilMethimazole

Autor:innen und Institutionen

  • Seoul National University Hospital, Seoul, Republic of Korea.
  • Department of Medicine, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.
  • Division of Pediatric Cardiology, Department of Pediatrics, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Samsung Medical Center, Seoul, Republic of Korea.
  • Department of Precision Medicine, Sungkyunkwan University School of medicine, Suwon, Republic of Korea.
  • Department of Internal Medicine IV, Nephrology and Hypertension, Medical University Innsbruck, Innsbruck, Austria.

ORCID-Profile: Jun Myong Lee, Eun Young Kim

Zitieren

APA

Han, J. Y., Lee, J. M., Jung, S. Y., Kim, M. S., Lee, S. W., Kronbichler, A., Tizaoui, K., Koyanagi, A., Kim, E. Y., Song, K., Chae, H. W., Yon, D. K., Shin, J. I., & Smith, L. (2024). Comparison of agranulocytosis and anti‐neutrophil cytoplasmic antibody‐associated vasculitis caused by two antithyroid drugs: A pharmacovigilance study using the WHO international database. Fundamental & Clinical Pharmacology, 38(4), 780-788. https://doi.org/10.1111/fcp.12991

Vancouver

Han JY, Lee JM, Jung SY, Kim MS, Lee SW, Kronbichler A, et al. Comparison of agranulocytosis and anti‐neutrophil cytoplasmic antibody‐associated vasculitis caused by two antithyroid drugs: A pharmacovigilance study using the WHO international database. Fundamental & Clinical Pharmacology. 2024;38(4):780-788. doi:10.1111/fcp.12991

BibTeX
@article{Han2024,
  author = {Han, Ji Yun and Lee, Jun Myong and Jung, Se Yong and Kim, Min Seo and Lee, Seung Won and Kronbichler, Andreas and Tizaoui, Kalthoum and Koyanagi, Ai and Kim, Eun Young and Song, Kyungchul and Chae, Hyun Wook and Yon, Dong Keon and Shin, Jae Il and Smith, Lee},
  title = {Comparison of agranulocytosis and anti‐neutrophil cytoplasmic antibody‐associated vasculitis caused by two antithyroid drugs: A pharmacovigilance study using the WHO international database},
  journal = {Fundamental & Clinical Pharmacology},
  year = {2024},
  volume = {38},
  number = {4},
  pages = {780--788},
  doi = {10.1111/fcp.12991}
}
Kostenlos starten →